NewslettersMammary Cell NewsAtossa Therapeutics Announces Plans to Pursue Metastatic Breast Cancer Indication for (Z)-Endoxifen and Continued Engagement with FDA on Additional IndicationsBy Jamie Kang - March 13, 2025013Atossa Therapeutics, Inc. announced its strategic decision to pursue a metastatic breast cancer indication for (Z)-endoxifen.[Atossa Therapeutics, Inc.]Press Release